SCHEMBL1847016

SCHEMBL1847016

O=S(=O)(O)OO.O=S(=O)(O)OS(=O)(=O)OO

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.37
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624 0.97 CA2 (0.39) CA2TSHRTDP1
SCHEMBL2680156 0.94 CA2 (0.37) CA2TSHRTDP1
Ammonia Solution, Strong SCHEMBL35790 0.94 CA2 (0.37) CA2TSHRTDP1
SCHEMBL513155 0.94 CA2 (0.37) CA2TSHRTDP1
Ammonia Solution, Strong SCHEMBL7119873 0.94 CA2 (0.37) CA2TSHRTDP1
Sulfuric Acid SCHEMBL10645863 0.94 CA5A (0.38) CA2TSHRTDP1
Sulfuric Acid SCHEMBL14481302 0.91 CA5A (0.35) CA2TSHRTDP1
Ammonia Solution, Strong SCHEMBL10698109 0.91 CA2 (0.35) CA2TSHRTDP1
Sulfuric Acid SCHEMBL41847 0.91 CA5A (0.35) CA2TSHRTDP1
Ammonia Solution, Strong SCHEMBL6862916 0.91 CA2 (0.35) CA2TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2457656-B1 CATALYST PRECURSOR, METHOD FOR PRODUCING THE SAME, METHOD FOR USING THE SAME, AND REACTOR THAT USES THE SAME NAT UNIV CORP HOKKAIDO UNIV (JP) 2016-12-14 EP disclosed
US-9175004-B2 Catalyst precursor, method for producing the same, method for using the same, and reactor that uses the same NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2015-11-03 US disclosed
EP-2457656-A1 CATALYST PRECURSOR, METHOD FOR PRODUCING THE SAME, METHOD FOR USING THE SAME, AND REACTOR THAT USES THE SAME National University Corporation Hokkaido University (JP) 2012-05-30 EP disclosed
US-20120115714-A1 CATALYST PRECURSOR, METHOD FOR PRODUCING THE SAME, METHOD FOR USING THE SAME, AND REACTOR THAT USES THE SAME FURUYA METAL CO., LTD. (JP) 2012-05-10 US disclosed
US-20110262120-A1 LIQUID HEATING APPARATUS AND LIQUID HEATING METHOD KURITA WATER INDUSTRIES LTD. 2011-10-27 US disclosed
EP-2325574-A1 LIQUID HEATER AND LIQUID HEATING METHOD Kurita Water Industries Ltd. (JP) 2011-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115714-A1 CATALYST PRECURSOR, METHOD FOR PRODUCING THE SAME, METHOD FOR USING THE SAME, AND REACTOR THAT USES THE SAME SRMS, SEM1, SOD1 CA2 2506/4885TSHR 2779/4885TDP1 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.